Why the study?
Do stentless glutaraldehyde-preserved bioprosthetic valves improve haemodynamic characteristics and clinical outcomes compared to stented porcine bioprostheses in the aortic position?
Do stentless glutaraldehyde-preserved bioprosthetic valves improve haemodynamic characteristics and clinical outcomes compared to stented porcine bioprostheses in the aortic position?
Despite demonstrating superior haemodynamic profiles and more complete regression of left ventricular hypertrophy, stentless aortic valves have not been widely adopted in clinical practice.
Answers are grounded in this paper and cite their sources.
Stentless valves' hemodynamic advantages remain underutilized; leaves open whether randomized trials would shift current practice.
Stentless glutaraldehyde-preserved bioprosthetic valves for the aortic position were introduced into clinical practice in 1988. Their introduction coincided with the publication of several long-term observational studies of aortic homografts, which showed superior freedom from structural valve damage compared to the first generation stented porcine bioprosthesis. There followed 10 years of intensive investigation into the haemodynamic characteristics of stentless valves. These studies have demonstrated superior haemodynamic features in terms of transvalvular pressure gradients, effective orifice area, and more complete regression of left ventricular hypertrophy. Despite these advantages, stentless valves have yet to be adopted widely. This review seeks to explain this paradox.
No takes yet. Share an insight, caveat, or question.
Xiu-Feng Jin (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: